相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Acute and Life-threatening Complications in Cushing Syndrome: Prevalence, Predictors, and Mortality
Marie Helene Schernthaner-Reiter et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Glucocorticoids dexamethasone and prednisolone suppress fibroblast growth factor 23 (FGF23)
Martina Feger et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2021)
Age-dependent sex differences in calcium and phosphate homeostasis
W. N. H. Koek et al.
ENDOCRINE CONNECTIONS (2021)
Cushing's Syndrome Effects on the Thyroid
Rosa Maria Paragliola et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Objectives, design and main findings until 2020 from the Rotterdam Study
M. Arfan Ikram et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2020)
The Effect of Biochemical Remission on Bone Metabolism in Cushing's Syndrome: A 2-Year Follow-Up Study
Leah T. Braun et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
Effects of Potassium or Sodium Supplementation on Mineral Homeostasis: A Controlled Dietary Intervention Study
Jelmer K. Humalda et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Glucocorticoid-induced osteoporosis: 2019 concise clinical review
G. Adami et al.
OSTEOPOROSIS INTERNATIONAL (2019)
Glucocorticoids Decrease Longitudinal Bone Growth in Pediatric Kidney Transplant Recipients by Stimulating the FGF23/FGFR3 Signaling Pathway
Angela Delucchi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
Disorders of phosphate metabolism
Jenny Leung et al.
JOURNAL OF CLINICAL PATHOLOGY (2019)
Associations of serum fibroblast growth factor 23 levels with obesity and visceral fat accumulation
Xiang Hu et al.
CLINICAL NUTRITION (2018)
Glucocorticoids and Bone: Consequences of Endogenous and Exogenous Excess and Replacement Therapy
Rowan S. Hardy et al.
ENDOCRINE REVIEWS (2018)
Serum phosphate is related to adiposity in healthy adults
Emma O. Billington et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2017)
Hypophosphatemia promotes lower rates of muscle ATP synthesis
Dominik H. Pesta et al.
FASEB JOURNAL (2016)
Complications of Cushing's syndrome: state of the art
Rosario Pivonello et al.
LANCET DIABETES & ENDOCRINOLOGY (2016)
Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
Lynnette K. Nieman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Hypophosphatemic Rickets: Lessons from Disrupted FGF23 Control of Phosphorus Homeostasis
Bracha K. Goldsweig et al.
CURRENT OSTEOPOROSIS REPORTS (2015)
Assessment of tubular reabsorption of phosphate as a surrogate marker for phosphate regulation in chronic kidney disease
Yu Ah Hong et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2015)
Serum Phosphorus and Mortality in the Third National Health and Nutrition Examination Survey (NHANES III): Effect Modification by Fasting
Alex R. Chang et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Hypophosphatemic rickets: etiology, clinical features and treatment
Vito Pavone et al.
European Journal of Orthopaedic Surgery and Traumatology (2014)
Phosphate Transporters and Their Function
Juerg Biber et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 75 (2013)
Causal Relationship between Obesity and Vitamin D Status: Bi-Directional Mendelian Randomization Analysis of Multiple Cohorts
Karani S. Vimaleswaran et al.
PLOS MEDICINE (2013)
Serum Leptin, Parathyroid Hormone, 1,25-Dihydroxyvitamin D, Fibroblast Growth Factor 23, Bone Alkaline Phosphatase, and Sclerostin Relationships in Obesity
Elizabeth Grethen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Approach to the Hypophosphatemic Patient
Erik A. Imel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Hypophosphatemia Related to Paraneoplastic Cushing Syndrome in Prostate Cancer: Cure After Bilateral Adrenalectomy
Isolde Ramon et al.
CALCIFIED TISSUE INTERNATIONAL (2011)
ACTH is a novel regulator of bone mass
Carlos M. Isales et al.
SKELETAL BIOLOGY AND MEDICINE (2010)
Leptin Stimulates Fibroblast Growth Factor 23 Expression in Bone and Suppresses Renal 1α,25-Dihydroxyvitamin D3 Synthesis in Leptin-Deficient Mice
Kiyomi Tsuji et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
ACTH protects against glucocorticoid-induced osteonecrosis of bone
Mone Zaidi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Medication-induced hypophosphatemia: a review
G. Liamis et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Serum phosphate levels and the risk of cardiovascular disease and metabolic syndrome: A double-edged sword
Wan Park et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2009)
Differential regulation of the renal sodium-phosphate cotransporters NaPi-IIa, NaPi-IIc, and PiT-2 in dietary potassium deficiency
Sophia Y. Breusegem et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients - Proposal of diagnostic criteria using FGF23 measurement
Itsuro Endo et al.
BONE (2008)
Hypophosphatemia as unusual cause of ARDS in Cushing's syndrome secondary to ectopic CRH production. A case report
Stefania Mondello et al.
THESCIENTIFICWORLDJOURNAL (2008)
Hypophosphatemia: an evidence-based approach to its clinical consequences and management
J Amanzadeh et al.
NATURE CLINICAL PRACTICE NEPHROLOGY (2006)
Glomerular filtration rate in patients with Cushing's disease: a matched case-control study
P Haentjens et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission
A Faggiano et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
分享论文
